0001437107 false 0001437107 2025-04-08 2025-04-08 0001437107 us-gaap:CommonClassAMember 2025-04-08 2025-04-08 0001437107 disca:SeniorNotesDue20304.302Member 2025-04-08 2025-04-08 0001437107 disca:SeniorNotesDue20304.693Member 2025-04-08 2025-04-08
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 8, 2025
Warner Bros. Discovery, Inc.
(Exact name of registrant as specified in its charter)
Commission File Number: 001-34177

Delaware |  | 35-2333914
(State or other jurisdiction of incorporation) |  | (IRS Employer Identification No.)

230 Park Avenue South
New York, New York 10003
(Address of principal executive offices, including zip code)
212-548-5555
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[☐] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[☐] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[☐] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[☐] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Series A Common Stock |  | WBD |  | Nasdaq Global Select Market
4.302% Senior Notes due 2030 |  | WBDI30 |  | Nasdaq Global Market
4.693% Senior Notes due 2033 |  | WBDI33 |  | Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On April 8, 2025, Dr. John Malone notified the Board of Directors (the “Board”) of Warner Bros. Discovery, Inc. (the “Company”) of his decision to not stand for re-election following the expiration of his current term, which will expire at the Company's 2025 Annual Meeting of Stockholders. Dr. Malone is chair of the Company's Nominating and Corporate Governance Committee. His decision not to stand for re-election was not the result of any disagreement with the Company on any matter relating to the Company's operation, policies or practices.
On April 9, 2025, in recognition of Dr. Malone’s service to the Company and his continued interest in contributing to and supporting the Company with his counsel, the Board designated Dr. Malone as Chair Emeritus of the Board, effective as of the Company’s 2025 Annual Meeting of Stockholders. As Chair Emeritus, Dr. Malone will continue to regularly attend Board meetings in an advisory capacity, but will not vote on Board matters.
The Company had previously filed a Form 8-K on March 31, 2025 announcing (i) that the Board had adopted a resolution to increase the size of the Board to fourteen directors, effective immediately following the Company’s 2025 Annual Meeting of Stockholders, as permitted under the Company’s Second Restated Certificate of Incorporation and the Company’s Amended and Restated Bylaws and (ii) that following the future increase in the size of the Board and in accordance with the procedures set forth in the Company's Second Restated Certificate of Incorporation, on March 31, 2025, the Board had appointed Anton Levy to the Board effective immediately following the 2025 Annual Meeting of Stockholders.
On April 9, 2025, in light of Dr. Malone’s decision not to stand for re-election, the Board adopted a resolution to nominate Mr. Levy for election at the Company's 2025 Annual Meeting of Stockholders with a term that expires at the 2026 Annual Meeting of Stockholders and maintain the size of the Board at thirteen directors following the Company's 2025 Annual Meeting of Stockholders.
Item 7.01. Regulation FD Disclosure
On April 11, 2025, the Company issued a press release announcing Dr. Malone's decision to not stand for re-election. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
The information furnished pursuant to Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.
-2-

Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.

Exhibit Number | Description
99.1 | Press Release of Warner Bros. Discovery, Inc., dated April 11, 2025
101 | Inline XBRL Instance Document - the instance document does not appear in the Interactive Date File because its XBRL tags are embedded within the Inline XBRL document
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document)

-3-

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

|  |  |  |  | Warner Bros. Discovery, Inc.
Date: April 11, 2025 |  |  | By: | /s/ Tara L. Smith
|  |  |  |  |  | Tara L. Smith
|  |  |  |  |  | Executive Vice President and Corporate Secretary

-4-